Diagnostic timelines and self-reported symptoms of patients with lung and gastrointestinal cancers undergoing radiation therapy. Retrospective case control study.
Oncology
Patient experience
Patient-centred care
Symptom severity
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
17
03
2021
accepted:
25
08
2021
pubmed:
18
9
2021
medline:
7
1
2022
entrez:
17
9
2021
Statut:
ppublish
Résumé
Previous studies have found that patients with lung cancer report worse patient experience compared to other tumour groups. Reasons that may negatively impact patient experience include delays in diagnosis as well as inadequate symptom management. The purpose of this study was to compare the diagnostic timelines and symptom reports of patients with lung and gastrointestinal (GI) cancers. This study included patients diagnosed with lung or GI cancers who attended a radiation oncology (RO) consultation and/or received radiation treatment between May and August 2019 at the Tom Baker Cancer Centre, Calgary, Alberta, Canada. Data collected included demographics, dates of diagnostic time points, and self-reported symptom scores across 3 time points. A descriptive analysis was completed, and the median number of days between time points was compared between tumour groups. Patients with lung cancer had longer diagnostic timelines compared to GI patients. The median number of days between the first investigative test and biopsy was 21 days longer for patients with lung cancer (p < 0.05). From RO consultation to the first treatment review appointment, 25% and 4% of lung and GI patients, respectively, reported worsening of symptoms. A greater proportion of lung patients reported worse symptom scores during treatment compared to GI patients. This varied by specific symptom. Patients with lung cancer experienced delays in receiving a diagnosis and worse symptom burden during radiation therapy in this study. We identified potential targets to improve patient experience.
Sections du résumé
BACKGROUND
BACKGROUND
Previous studies have found that patients with lung cancer report worse patient experience compared to other tumour groups. Reasons that may negatively impact patient experience include delays in diagnosis as well as inadequate symptom management. The purpose of this study was to compare the diagnostic timelines and symptom reports of patients with lung and gastrointestinal (GI) cancers.
METHODS
METHODS
This study included patients diagnosed with lung or GI cancers who attended a radiation oncology (RO) consultation and/or received radiation treatment between May and August 2019 at the Tom Baker Cancer Centre, Calgary, Alberta, Canada. Data collected included demographics, dates of diagnostic time points, and self-reported symptom scores across 3 time points. A descriptive analysis was completed, and the median number of days between time points was compared between tumour groups.
RESULTS
RESULTS
Patients with lung cancer had longer diagnostic timelines compared to GI patients. The median number of days between the first investigative test and biopsy was 21 days longer for patients with lung cancer (p < 0.05). From RO consultation to the first treatment review appointment, 25% and 4% of lung and GI patients, respectively, reported worsening of symptoms. A greater proportion of lung patients reported worse symptom scores during treatment compared to GI patients. This varied by specific symptom.
CONCLUSIONS
CONCLUSIONS
Patients with lung cancer experienced delays in receiving a diagnosis and worse symptom burden during radiation therapy in this study. We identified potential targets to improve patient experience.
Identifiants
pubmed: 34533629
doi: 10.1007/s00520-021-06522-0
pii: 10.1007/s00520-021-06522-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1501-1509Informations de copyright
© 2021. Crown.
Références
Canadian Institute for Health Information. Patient experience. CIHI. Published 2020. https://www.cihi.ca/en/patient-experience%0D . Accessed October 28, 2020
Wolf JA, Niederhauser V, Marshburn D, Lavela SL (2014) Defining patient experience. Patient Exp J 1(1):7–19. https://doi.org/10.35680/2372-0247.1004
doi: 10.35680/2372-0247.1004
Lines LM, Lepore M, Wiener JM (2015) Patient-centered, person-centered, and person-directed care: they are not the same. Med Care 53(7):561–563. https://doi.org/10.1097/MLR.0000000000000387
doi: 10.1097/MLR.0000000000000387
pubmed: 26067878
The Beryl Institute. Defining patient experience. The Beryl Institute. https://www.theberylinstitute.org/page/definingpatientexp . Accessed October 28, 2020
Biddy R, Griffin C, Johnson N, Al E (2015) Person-centered care guideline
Ekman I, Swedberg K, Taft C et al (2011) Person-centered care - ready for prime time. Eur J Cardiovasc Nurs 10(4):248–251. https://doi.org/10.1016/j.ejcnurse.2011.06.008
doi: 10.1016/j.ejcnurse.2011.06.008
pubmed: 21764386
Yannitsos D, Grendarova P, Al-Rashdan A et al (2019) Patient experience in radiation oncology
Fitch MI (2019) The changing face of lung cancer: survivor perspectives on patient engagement. Asia-Pac J Oncol Nurs 6(1):17–23. https://doi.org/10.4103/apjon.apjon-43-18
doi: 10.4103/apjon.apjon-43-18
pubmed: 30599011
pmcid: 6287379
Tsianakas V, Robert G, Maben J, Richardson A, Dale C, Wiseman T (2012) Implementing patient-centred cancer care: using experience-based co-design to improve patient experience in breast and lung cancer services. Support Care Cancer 20(11):2639–2647. https://doi.org/10.1007/s00520-012-1470-3
doi: 10.1007/s00520-012-1470-3
pubmed: 22544223
pmcid: 3461206
Dy SM, Janssen EM, Ferris A, Bridges JF (2017) Live, Learn, Pass It on. J Patient Exp 4(4):162–168. https://doi.org/10.1177/2374373517714451
doi: 10.1177/2374373517714451
pubmed: 29276762
pmcid: 5734514
Bravi F, Di Ruscio E, Frassoldati A et al (2018) Patient and health care professional perspectives: a case study of the lung cancer integrated care pathway. Int J Integr Care 18(4):1–13. https://doi.org/10.5334/ijic.3972
doi: 10.5334/ijic.3972
Mokhles S, Nuyttens JJME, de Mol M et al (2018) Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making. BMC Cancer 18(1):1–10. https://doi.org/10.1186/s12885-018-3986-5
doi: 10.1186/s12885-018-3986-5
Sanders SL, Bantum EO, Owen JE, Thornton AA, Stanton AL (2010) Supportive care needs in patients with lung cancer. Psychooncology 19(5):480–489. https://doi.org/10.1002/pon.1577
doi: 10.1002/pon.1577
pubmed: 19434625
Cuthbert CA, Watson L, Xu Y, Boyne DJ, Hemmelgarn BR, Cheung WY (2019) Patient-reported outcomes in Alberta: rationale, scope, and design of a database initiative. Curr Oncol 26(4):e503–e509. https://doi.org/10.3747/co.26.4919
doi: 10.3747/co.26.4919
pubmed: 31548818
pmcid: 6726254
Watanabe S, Nekolaichuk C, Beaumont C, Mawani A (2009) The Edmonton symptom assessment system-what do patients think? Support Care Cancer 17(6):675–683. https://doi.org/10.1007/s00520-008-0522-1
doi: 10.1007/s00520-008-0522-1
pubmed: 18953577
Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F (2011) A multicenter study comparing two numerical versions of the Edmonton symptom assessment system in palliative care patients. J Pain Symptom Manage 41(2):456–468. https://doi.org/10.1016/j.jpainsymman.2010.04.020
doi: 10.1016/j.jpainsymman.2010.04.020
pubmed: 20832987
Selby D, Cascella A, Gardiner K et al (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton symptom assessment system. J Pain Symptom Manag 39(2):241–249. https://doi.org/10.1016/j.jpainsymman.2009.06.010
doi: 10.1016/j.jpainsymman.2009.06.010
Bruix J, Llovet JM (2009) Major achievements in hepatocellular carcinoma. Lancet 373(9664):614–616. https://doi.org/10.1016/S0140-6736(09)60381-0
doi: 10.1016/S0140-6736(09)60381-0
pubmed: 19231618
Wait Time Alliance. Cancer care: wait time benchmarks for cancer care. Wait Time Alliance. Published 2014. https://www.waittimealliance.ca/benchmarks/cancer-care/ . Accessed October 30, 2020
Howell D, Keshavarz H, Esplen MJ, Hack T, Hamel M, Howes J, Jones J, Li M, Manii D, McLeod D, Mayer C, Sellick S, Riahizadeh S, Noroozi H, Ali M, on behalf of the Cancer Journey Advisory Group of the Canadian Partnership Against Cancer (2015) A Pan Canadian Practice Guideline: screening, Assessment and care of psychosocial distress, depression, and anxiety in adults with cancer. Canadian Partnership Against Cancer and the Canadian Association of Psychosocial Oncology, Toronto
Li M, Kennedy EB, Byrne N, Gérin-Lajoie C, Katz MR, Keshavarz H, Sellick S, Green E (2016) Management of depression in patients with cancer: a clinical practice guideline. J Oncol Pract 12(8):747–756. https://doi.org/10.1200/JOP.2016.011072
doi: 10.1200/JOP.2016.011072
pubmed: 27382000
Clover KA, Mitchell AJ, Britton B, Carter G (2015) Why do oncology outpatients who report emotional distress decline help? Psychooncology 24(7):812–818. https://doi.org/10.1002/pon.3729
doi: 10.1002/pon.3729
pubmed: 25504987
Carolan CM, Smith A, Davies GR, Forbat L (2018) Seeking, accepting and declining help for emotional distress in cancer: a systematic review and thematic synthesis of qualitative evidence. Eur J Cancer Care (Engl) 27(2):1–26. https://doi.org/10.1111/ecc.12720
doi: 10.1111/ecc.12720
Mosher C, Joseph W, Hanna N et al (2014) Barriers to mental health service use and preference for addressing emotional concerns among lung cancer patients. Psychooncology 23(7):812–819. https://doi.org/10.1002/pon.3488.Barriers
doi: 10.1002/pon.3488.Barriers
pubmed: 24493634
pmcid: 4082441
Halpern MT, Urato MP, Lines LM, Cohen JB, Arora NK, Kent EE (2018) Healthcare experience among older cancer survivors: analysis of the SEER-CAHPS dataset. J Geriatr Oncol 9(3):194–203. https://doi.org/10.1016/j.jgo.2017.11.005
doi: 10.1016/j.jgo.2017.11.005
pubmed: 29249645
Ayanian JZ, Zaslavsky AM, Arora NK et al (2010) Patients’ experiences with care for lung cancer and colorectal cancer: findings from the cancer care outcomes research and surveillance consortium. J Clin Oncol 28(27):4154–4161. https://doi.org/10.1200/JCO.2009.27.3268
doi: 10.1200/JCO.2009.27.3268
pubmed: 20713876
pmcid: 2953972
Chen J, Ou L, Hollis S (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13:211. https://doi.org/10.1186/1472-6963-13-211
doi: 10.1186/1472-6963-13-211
pubmed: 23758898
pmcid: 3700832
Kotronoulas G, Kearney N, Maguire R et al (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health services outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32(14):1480–1501. https://doi.org/10.1200/JCO.2013.53.5948
doi: 10.1200/JCO.2013.53.5948
pubmed: 24711559
Barbera L, Lee F, Sutradhar R (2019) Use of patient-reported outcomes in regional cancer centres over time: a retrospective study. CMAJ Open 7(1):E101–E108. https://doi.org/10.9778/cmajo.20180074
doi: 10.9778/cmajo.20180074
pubmed: 30782773
pmcid: 6380903
Mahar AL, Davis LE, Bubis LD et al (2019) Factors associated with receipt of symptom screening in the year after cancer diagnosis in a universal health care system: a retrospective cohort study. Curr Oncol 26(1):e8–e16. https://doi.org/10.3747/co.26.4160
doi: 10.3747/co.26.4160
pubmed: 30853804
pmcid: 6380655